32 results on '"Pekcetin, C."'
Search Results
2. Antioxidant and Antiapoptotic Activities of Deprenyl and Estradiol Co-Administration in Aged Rat Kidney
- Author
-
Kiray, Muge, Bagriyanik, H. A., Ergur, B. U., Pekcetin, C., and Topcu, Ayca
- Published
- 2009
- Full Text
- View/download PDF
3. The effect of ferulic acid on experimental traumatic brain damage in rats
- Author
-
Erbil, G., primary, Sacik, U., additional, Yilmaz, F., additional, Kisaoglu, H., additional, Erbayraktar, Z., additional, Pekcetin, C., additional, and Ozogul, C., additional
- Published
- 2019
- Full Text
- View/download PDF
4. Poster presentations
- Author
-
Aksu F, Topacoglu H, Arman C, Atac A, Tetik S, Hasanovic A, Kulenovic A, Mornjakovic Z, Pikula B, Sarac-Hadzihalilovic A, Voljevica A, Bamac B, Colak T, Alemdar M, Dundar G, Selekler M, Dincer O, Colak E, Ozbek A, Kilic C, Kamburoglu K, Ozen T, Kavak V, Kirici Y, Oztas E, Soysal HA, Unur E, Ekinci N, Karaca O, Malakhova O, Kocaoglu M, Toker S, Taser F, Kilincoglu V, Yurtgun MF, Dalcik C, Zeybek A, Baroncini M, Peltier J, Jissendi P, Pruvo JP, Francke JP, Prevot V, Kosif R, Arifoglu Y, Diramali M, Sarsilmaz M, Kose E, Ogeturk M, Akpinar B, Kus I, Meydan S, Kara A, Kurtoglu Z, Tekdemir I, Elhan A, Bas O, Odaci E, Mollaoglu H, Ucok K, Kaplan S, Senoglu M, Nacitarhan V, Kurutas EB, Senoglu N, Altun I, Atli Y, Ozbag D, Karakas S, Bilgin MD, Tellioglu AM, Ozlem S, Akcanal B, Yildiz Y, Gunes H, Kose H, Uzum I, Gundogmus UN, Caglayan C, Pavlova V, Dimitrova M, Georgieva L, Nikolova E, Uzmansel D, Ozturk NC, Saylam CY, Ozgiray E, Orhan M, Cagli S, Zileli M, Ozkan D, Akkaya T, Comert A, Balikci N, Ozdemir E, Gumus H, Ergul Z, Kaya O, Altun S, Unlu RE, Orbay H, Kim DI, Han SH, Kim YS, Kim HJ, Lee KS, Elcioglu O, Ozden H, Guven G, Imre N, Yalcin B, Ozan H, Akyer P, Guvencer M, Karatosun V, Sagoo MG, Aland RC, Ustuner D, Ustuner MC, Ai J, Ghazi SR, Mansouri SH, Tuncer MC, Aluclu MU, Karabulut O, Hatipoglu ES, Nazaroglu H, Icke C, Akbay E, Gunay T, Icke S, Yildiz S, Yazar F, Barlas BO, Zahoi DE, Kavakli A, Tas U, Dabak DO, Sapmaz HI, Kocabiyik N, Ozer CM, Ozcan A, Elevli L, Desdicioglu K, Alanbay I, Govsa F, Akdogan I, Kiroglu Y, Onur S, Evcil EH, Cankara N, Malas MA, Kalcioglu MT, Duman S, Ulcay T, Uzun A, Karabulut Z, Barut C, Sevinc O, Yurdakan G, Kacar D, Erdogan AR, Kurt H, Demir B, Saltan M, Burukoglu D, Degirmenci I, Erdogan A, Damar O, Is M, Bayramoglu G, Kabay S, Uysal O, Senturk H, Bayramoglu A, Ozbayar C, Kutlu A, Canbek M, Cevli SC, Hancerlioglu O, Koplay M, Aksakalli E, Dikici F, Kale A, Gayretli O, Gurses IA, Ozdemir ST, Ercan I, Baskan EB, Yilmaz M, Ozkaya G, Saricaoglu H, Erturk M, Kayalioglu G, Uzel M, Kahraman G, Tanyeli E, Soyluoglu AI, Tacar O, Demirant A, Bilgin M, Karadede A, Aktas A, Koyuncu E, Sulak O, Albay S, Ozguner G, Ozbek E, Ozturk AH, Demirci T, Ciftcioglu E, Demir MT, Kopuz C, Eroglu E, Gedikli S, Ozyurek H, Nural MS, Incesu L, Ogur G, Kara E, Celebi B, Yildiz A, Altunkaynak BZ, Kuvat SV, Tagil SM, Ertekin C, Uysal H, Bademkiran F, Albayrak N, Esmer AF, Coskun NK, Sindel M, Kizilay F, Yalin S, Karapinar N, Tokdemir M, Karakurt L, Tumkaya L, Korkmaz A, Ayas B, Ciftci N, Terzi Y, Baran O, Nergiz Y, Akkus M, Aluclu U, Topal AE, Yuksel D, Acar HI, Kendir S, Hekimoglu E, Basman D, Ozener B, Pelin C, Zagyapan R, Kurkcuoglu A, Koc M, Erdinc M, Erdinc L, Kelle I, Sancakdar E, Cetin N, Tunik S, Yildirim A, Kaplanoglu I, Ayaz E, Ilhan N, Okumus M, Yuksel KZ, Ciralik H, Yilmaz Z, Gumusalan Y, Gamsizkan M, Kazkayasi M, Unver Dogan N, Uysal II, Karalezli A, Fazliogullari Z, Buyukmumcu M, Bozkurt MC, Cicekcibasi AE, Demiryurek D, Ozsoy MH, Tuccar E, Baran OP, Soker S, Bahceci S, Nasir Y, Yilmaz MT, Cicekcibasi EA, Ulusoy M, Gunaslan P, Bilge N, Akkaya M, Genc A, Akcer S, Gonul Y, Cosar E, Koken G, Ari I, Bakirci S, Kafa IM, Uysal M, Karabulut AK, Keles B, Emlik D, Uyar Y, Ozturk K, Yilmaz NA, Salbacak A, Kacira BK, Arazi M, Demirci S, Kiresi D, Gumus S, Seker M, Uyar M, Astaneh ME, Khorshid A, Uygur R, Songur A, Sonmez OF, Dogan KH, Kolcu G, Iliescu M, Bordei P, Iliescu D, Ciobotaru C, Lucescu V, Covaleov A, Ionescu C, Guirao M, Páramo E, Mutuberria R, Sánchez-Montesinos I, Roda O, Girón F, Lopez-Soler M, Campos-López R, Guirao-Piñeiro M, Pascual-Morenilla MT, Sanchez-Montesinos I, Pascual MT, Garzon I, Serrato D, Nieto-Aguilar R, Sanchez-Quevedo M, Ozdemir MB, Ozean RH, Bagdatli D, Adiguzel E, Dogan Z, Aycan O, Vardi N, Erkal HS, Ozturk H, Mocanu S, Stefanescu C, Ionescu A, Talpes R, Sapte E, Dina C, Surdu L, Bulbuc I, Medina MT, Medina J, López-Soler M, Martin-Oviedo C, Lowy-Benoliel A, Maranillo E, Martinez-Guirado T, Sañudo J, Scola B, Vazquez T, Arráez-Aybar LA, Conejo-Menor JL, Gonzáles-Gómez CC, Torres-García AJ, Nasu H, Chiba S, Gutierrez-Semillera M, Paksoy Y, Kalaycioglu A, Yildirim M, Ozyasar A, Ozdogmus O, Cakmak YO, Verimli U, Cavdar S, Yildizhan B, Aktan Ikiz ZA, Ucerler H, Ozgur Z, Yilmaz S, Demirtas A, Mavili E, Hacialiogullari M, Susar H, Arslan S, Aycan K, Ozkaya V, Pilmane M, Boka S, Ortug G, Ramirez C, Pascual-Font A, Valderrama-Canales F, Kucukalic A, Kapur E, Talovic E, Baca V, Grill R, Horak Z, Kachlik D, Dzupa V, Konarik M, Knize J, Veleminsky P, Smrzova T, Otcenasek M, Chmelova J, Kheck M, Cupka T, Hnatek L, van der Meijs F, Cech P, Musil V, Ozkan HM, Muratli SK, Tayefi H, Ergur I, Kiray A, Toktas M, Alkoc O, Acar T, Uzun I, Ozen OA, Aycicek A, Alkoc OA, Unlu M, Corumlu U, Ikiz IC, Oygucu IH, Sendemir E, Kaner T, Caglar V, Eser O, Iyigun O, Pirzirenli G, Kaya AH, Aydin ME, Celik F, True H, Ozkaya S, Ergur BU, Zeybek G, Bacakoglu K, Tadjalli M, Poostpasand A, Mansouiri SH, Allahvaisi O, Soleimanirad J, Nikkhoo B, Nagato Y, Haruki Y, Yazawa K, Okazaki T, Haida M, Imai Y, Peirouvi T, Mahzad-Sadaghiani M, Noroozinia F, Siamak S, Farjah G, Mola S, Biegaj E, Skadorwa T, Pawlewicz K, Kapolka R, Chachulska A, Zabicka J, Krasowska A, Prusik A, Jaczewski G, Kolesnik A, Taghavi MM, Alavi SH, Moallem SA, Safikhani Z, Panahi M, Dabiri S, Shekaari MA, Latorre R, Soria F, Lopez-Albors O, Sarria R, Ayala I, Serrano I, Perez-Cuadrado E, Musienko V, Tkachenko D, Colakoglu N, Kus MA, Jalali M, Nikravesh MR, Moeen AA, Karimfar MH, Rafighdoost H, Mohammadi S, Korneeva M, Rafighdoust H, Lovasova K, Bolekova A, Kluchova D, Sulla I, Kapitonova MY, Syed Ahmad Fuad SB, Jayakaran F, Shams AR, Aghaee F, Baqer Z, Faroki M, Das S, Kassim N, Latiff A, Suhaimi F, Ghafar N, Hlaing KP, Maatoq I, Othman F, Kiray M, Bagriyanik HA, Pekcetin C, Ozogul C, Fidan M, Sun F, Sanchez-Margallo F, Gil F, Crisostomo V, Uson J, Ramirez G, Turamanlar O, Kirpiko O, Haktanir A, Climent S, Losilla S, Climent M, Sarikcioglu L, Senol Y, Yildirim FB, Utuk A, Kunicki J, Pasbakhsh P, Omidi N, Omidi H, Nazhvani FD, Ghalebi SR, Javan N, Mohagery A, Bideskan AR, Taheri MM, Fazel AR, Tiengo C, Macchi V, Stecco C, Porzionato A, Mazzoleni F, De Caro R, Clemente A, Morra A, Greco P, Pavan P, Natali A, Demir M, Dokur M, Acer N, Mavi A, Matveeva N, Lazarova D, Korneti K, Jovevska S, Jurkovik D, Papazova M, Havasi M, Alboghobeish N, Savari A, Salamat N, Sharifi M, Kwak HH, Hu KS, Kim GC, Park BS, Sinav A, Gulati AK, Gulati NK, Alshammary H, Nazhvani SD, Vafafar A, Esmaeilpour T, Bahmanpour S, Elyasi L, Monabbati A, Ghanadi M, Paryani MR, Gilanpour H, Amirsam B, Omaña RE, López SG, De la Garza Castro O, Vega EU, Lopez SG, Talebpour F, Golmohammadi R, Dashti G, Atlasi MA, Mehdizadeh M, Bahadori MH, Joghataei MT, Hatami L, Boroujeni MB, Estakhr J, Esfandiary E, Marzban M, Bakhtiary M, Modiry N, Jafarpur M, Mofidpur H, Mahmoudian A, Jafarpour M, Mahmoudian AR, Sanjarmousavi N, Doassans I, Sorrenti N, Decuadro G, Saibene A, Poumayrac M, Laza S, Almiron C, Vergara ME, Soria V, Lasa S, Perez A, Castro G, Maria AS, Soleimani M, Katebi M, Bakhshayesh M, Oner M, Halici M, Yikilmaz A, Guney A, Turk Y, Edizer M, Beden U, Icten N, Afshar M, Hasanzadeh Taheri MM, Moalem A, Golalipour MJ, Tamizi A, Ahi M, Mohammadpour S, Maiery A, Acikel C, Ulkur E, Karagoz H, Celikoz B, Bedi K, Ginus P, Golalipoor MJ, Mohammadi MR, Jhand P, Mansourian AR, Hosseinpoor K, Keshtkar AA, Alsaffar R, Balajadeh BK, Ghafari S, Azarhosh R, Fazeli SA, Jahanshahi M, Gharravi AM, Alicioglu B, Karakas HM, Harma A, Yang HM, Won SY, Lee JG, Lee JY, Kim YR, Song WC, Koh KS, Hwang EN, Choi HG, Kim SH, Kim SY, Hur MS, Ulucam E, Celbis O, Kim DH, Hong HS, Choi JH, Park JT, Kim HC, Abbasi H, Hosseinipanah SM, Hosseini M, Amani A, Ashrafi HR, Sadeghimehr M, Sheverdin V, Amani Z, Ashrafi A, Ashrafi AR, Javad H, Kachap MJ, Poumayrac MC, Almirón C, Rivara A, Sirilo A, Freire D, Cirillo A, Veragara ME, Krmek V, Krmek N, Jo-Osvatic A, Nikolic V, Radic R, Tubbs RS, Loukas M, Fogg Q, Ashwood N, Cilingiroglu S, Ozbakir C, Mazoochi T, Sabanciogullari V, Gumus C, Erdil FH, Cimen M, Moodi H, Ghiasi F, Akbari A, Hami J, Khazei M, Haghparast E, Mitsakis I, Anastasiou A, Mitsakis M, Sianou K, Hainoglou R, Francisco M, Mitsaki C, Konstantinidi M, Prapa S, Leksan I, Mrcela T, Selthofer R, Kermanian F, Ahmadpoor ME, Dalili N, Elian AH, Moaiery A, Jamalpour Z, Nourani MR, Asgari A, Hassanzadeh Taheri MM, Ebrahimzadeh A, Eftekharvaghefi SH, Mohammadi A, Sheibani V, Nematollahi-Mahani SN, Latifpour M, Deilami M, Soroure-Azimzadeh B, Nabipour F, Najafipour H, Nakhaee N, Yaghoobi M, Eftekharvaghefi R, Salehinejad P, Azizi H, Riasi HR, Nobakht M, Asalgoo S, Rahbar R, Najafzadeh N, Moosavizadeh K, Ezzatabadypour M, Majidi M, Malekpor-Afshar R, Karimzade F, Hoseini M, Bayat M, Gorgi A, Nezhadi A, Bakhtiari M, Jazi HR, Jafaryan M, Haghir H, Rahimi S, Rassouli FB, Gorji A, Habibi A, Pouya F, Mousavi A, Rajabalian S, Abolidokht A, Khanlarkhani N, Naderian H, Berjis N, Namavar MR, Talaei T, Mazaheri Z, Monabati A, Kosar MI, Karacan K, Chegini H, Nikzad H, Ayhan E, Ustundag S, Akkin SM, Ogut T, Rayegan P, Meibodi MA, Ghaem RM, Zargarpoor R, Eftekhar Vaghefi SH, Moshkdanian G, Poya F, Kohestani H, Abarghoeai RR, Abarghoeai PR, Mahmodi AA, Poraboli A, Kohestani HR, Vaghefi RE, Eftekhar Vaghefy SH, Vaghefy RE, Saba M, Javadnia F, Zhaleh M, Nezhad DB, Gholami MR, Piagkou M, Aikaterini VK, Piagkos G, Douvetzemis S, Skandalakis P, Anagnostopoulou S, Papadopoulos N, Celik HH, Tatar I, Tatar EC, Mocan BO, Sargon MF, Denk CC, Rasoolijazi H, Joghataie MT, Roghani M, Dinc G, Kurklu M, Ozboluk S, Komurcu M, Koebke J, Balioglu MB, Kaygusuz MA, Bozkus FS, Korkmaz O, Bayram SB, Can MA, Nasiri E, Jafar-Kazemi K, Maghoul S, Amini A, Hassanzade MM, Davari MH, Van Hoof T, Gomes GT, Audenaert E, Verstraete K, Kerckaert I, D'Herde K, Benninger B, Hedley G, Filipoiu FM, Tarta E, Enyedi M, Pantu C, Stanciulescu R, Skobowiat C, Calka J, Majewski M, Rezaian M, Yaghoobfar A, Hamedi S, and Shomali T
- Published
- 2009
5. The effects of ginkgo biloba extract (EGb 76) and selenium against rat cerebral ischemia reperfusion injury (IR/I)
- Author
-
Tugyan, K., Pekcetin, C., Ozogul, C., Ozbal, S., Kocdor, H., and Erbil, G.
- Published
- 2006
6. The effects of α-lipoic acid on immature rats with traumatic brain injury
- Author
-
Ozbal, S, primary, Cankurt, U, additional, Tugyan, K, additional, Pekcetin, C, additional, Sisman, Ar, additional, Gunduz, K, additional, and Micili, Sc, additional
- Published
- 2014
- Full Text
- View/download PDF
7. 83 THE PROTECTIVE EFFECT OF TRIMETAZIDINE ON THE RAT TESTES AFTER EXPOSURE TO ELECTROMAGNETIC FIELD
- Author
-
Nasrabadi, H. Tayefi, primary, Kiray, M., additional, Bagriyanik, A., additional, Pekcetin, C., additional, Ergur, B. Ugur, additional, Kiray, A., additional, and Ozogul, C., additional
- Published
- 2010
- Full Text
- View/download PDF
8. The effects of α-lipoic acid on immature rats with traumatic brain injury.
- Author
-
Ozbal, S, Cankurt, U, Tugyan, K, Pekcetin, C, Sisman, Ar, Gunduz, K, and Micili, Sc
- Subjects
BRAIN injuries ,LIPOIC acid ,RATS ,APOPTOSIS ,CHILD mortality - Abstract
Traumatic brain injury (TBI) is a leading cause of morbidity and mortality during childhood. TBI enhances formation of reactive oxygen species that cause neuron damage and apoptosis. α-Lipoic acid (LA) is a free radical scavenger and biological antioxidant. We investigated the effects of LA treatment on the parietal and prefrontal cortex, and on the hippocampal regions of the brain in 7-day-old rat pups that had been subjected to contusion injury. Forty-two male rats were divided randomly into a control group, a TBI group and a TBI + LA treated group. LA was administered 30 min after TBI through an intragastric tube once daily for 2 days. Forty-eight hours after TBI, the animals were sacrificed and tissues were examined for apoptosis and density of neurons. Terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling (TUNEL) and active caspase-3 immunostaining were used to detect apoptosis. Glutathione peroxidase (GPx), superoxide dismutase (SOD) activity and malondialdehyde (MDA) levels also were measured. Histological evaluation showed that LA treatment significantly reduced TBI-induced neuronal death in the hippocampus, prefrontal and parietal cortex; TUNEL- and caspase-3-positive cells also were decreased in the same regions. In addition, LA administration increased GPx and SOD activity in the prefrontal cortex. It appears that LA may be beneficial for TBI in rats. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
9. Deprenyl and the Relationship Between Its Effects on Spatial Memory, Oxidant Stress and Hippocampal Neurons in Aged Male Rats.
- Author
-
Kiray, M., Bagriyanik, H. A., Pekcetin, C., Ergur, B. U., Uysal, N., Ozyurt, D., and Buldan, Z.
- Subjects
SELEGILINE ,OXIDATIVE stress ,MEMORY ,HIPPOCAMPUS (Brain) ,LABORATORY rats - Abstract
Oxidative stress may play a major role in the aging process and associated cognitive decline. Therefore, antioxidant treatment may alleviate age-related impairment in spatial memory. Cognitive impairment could also involve the age-related morphological alterations of the hippocampal formation. The aim of this study was to examine the relationship between the effects of deprenyl, an irreversible monoamine-oxidase B inhibitor, on spatial memory by oxidant stress and on the total number of neurons in the hippocampus CAI region of aged male rats. In this study, 24-month-old male rats were used. Rats were divided into control and experimental groups which received an injection of deprenyl for 21 days. Learning experiments were performed for six days in the Morris water maze. Spatial learning was significantly better in deprenyl-treated rats compared to saline-treated rats. Deprenyl treatment elicited a significant decrease of lipid peroxidation in the prefrontal cortex, striatum and hippocampus regions and a significant increase of glutathione peroxidase activity in the prefrontal cortex and hippocampus. It was observed that deprenyl had no effect on superoxide dismutase activity. The total number of neurons in the hippocampus CAI region was significantly higher in the deprenyl group than in the control group. In conclusion, we demonstrated that deprenyl increases spatial memory performance in aged male rats and this increase may be related to suppression of lipid peroxidation and alleviation of the age-related decrease of the number of neurons in the hippocampus. The results of such studies may be useful in pharmacological alleviation of the aging process. [ABSTRACT FROM AUTHOR]
- Published
- 2006
- Full Text
- View/download PDF
10. The effects of single dose of methamphetamine on lipid peroxidation levels in the rat striatum and prefrontal cortex
- Author
-
Acikgoz, O., Gonenc, S., Kayatekin, B. M., Pekcetin, C., Uysal, N., Dayi, A., Semin, I., and Gure, A.
- Published
- 2000
- Full Text
- View/download PDF
11. Protective Effects of Deprenyl in Transient Cerebral Ischemia in Rats
- Author
-
Muge Kiray, Bagriyanik, H. A., Pekcetin, C., Ergur, B. U., and Uysal, N.
- Abstract
Cerebral ischemia leads to neuronal damage in the hippocampus and cognitive decline. Reactive oxygen species play an important role in the neuronal loss after cerebral ischemia and reperfusion injury. Deprenyl, an irreversible monoamine-oxidase B inhibitor, has antioxidant and neuroprotective effects against reactive oxygen species. In the present study, the effect of deprenyl on spatial memory impairment, oxidative stress and apoptotic neuronal cell death following transient cerebral ischemia in rats was investigated. Transient ischemia was induced by occlusion of left common carotid artery of rats for 30 min and reperfusion for 24 h or 1 week. Rats received intraperitoneal injection of 1 mg/kg deprenyl (n = 24) or equal volume of saline (n = 24) for 14 days before the experiment. Deprenyl treatment attenuated spatial memory deficits following ischemia-reperfusion as measured by the Morris water maze task. Deprenyl treatment elicited a significant decrease in lipid peroxidation and increase in superoxide dismutase activities in ischemic rat brains. The number of TUNEL-positive cells decreased significantly in deprenyl-treated group when compared with the control group. The results show that deprenyl reduces the ischemia-induced oxidative stress and thus prevents spatial memory deficits and apoptotic neuronal cell death when it is administered before ischemia-reperfusion. © 2008 by The Chinese Physiological Society.
12. Deprenyl and the relationship between its effects on spatial memory, oxidant stress and hippocampal neurons in aged male rats
- Author
-
Kiray, M., Bagriyanik, H. A., Pekcetin, C., Ergur, B. U., Nazan Uysal, Ozyurt, D., and Buldan, Z.
- Subjects
Male ,Neurons ,Aging ,Glutathione Peroxidase ,Monoamine Oxidase Inhibitors ,Superoxide Dismutase ,Physiology ,Prefrontal Cortex ,Spatial Behavior ,General Medicine ,Hippocampus ,Rats ,Neostriatum ,Oxidative Stress ,Memory ,Selegiline ,Animals ,Lipid Peroxidation ,Rats, Wistar - Abstract
Oxidative stress may play a major role in the aging process and associated cognitive decline. Therefore, antioxidant treatment may alleviate age-related impairment in spatial memory. Cognitive impairment could also involve the age-related morphological alterations of the hippocampal formation. The aim of this study was to examine the relationship between the effects of deprenyl, an irreversible monoamine-oxidase B inhibitor, on spatial memory by oxidant stress and on the total number of neurons in the hippocampus CA1 region of aged male rats. In this study, 24-month-old male rats were used. Rats were divided into control and experimental groups which received an injection of deprenyl for 21 days. Learning experiments were performed for six days in the Morris water maze. Spatial learning was significantly better in deprenyl-treated rats compared to saline-treated rats. Deprenyl treatment elicited a significant decrease of lipid peroxidation in the prefrontal cortex, striatum and hippocampus regions and a significant increase of glutathione peroxidase activity in the prefrontal cortex and hippocampus. It was observed that deprenyl had no effect on superoxide dismutase activity. The total number of neurons in the hippocampus CA1 region was significantly higher in the deprenyl group than in the control group. In conclusion, we demonstrated that deprenyl increases spatial memory performance in aged male rats and this increase may be related to suppression of lipid peroxidation and alleviation of the age-related decrease of the number of neurons in the hippocampus. The results of such studies may be useful in pharmacological alleviation of the aging process.
13. Methamphetamine causes lipid peroxidation and an increase in superoxide dismutase activity in the rat striatum
- Author
-
Acikgoz, O., Gonenc, S., Kayatekin, B. M., Uysal, N., Pekcetin, C., Semin, I., and Gure, A.
- Published
- 1998
- Full Text
- View/download PDF
14. The effect of skin transplantation on tumor growth in mice - dentritic cells as therapeutic reagents for the treatment of patients with cancer
- Author
-
Yolcuoglu, B., Onal, M.A., Sipahi, O., Temiz, A., Pekcetin, C., Acikgoz, O., Kar, H., and Gure, A.
- Published
- 1999
- Full Text
- View/download PDF
15. Therapeutic effects of melatonin on an ovalbumin-induced allergic rhinitis model in rats.
- Author
-
Cakir Cetin A, Ecevit MC, Gumustekin M, Pekcetin C, Ozbal S, Efe H, Koca P, Akcay O, and Tuncok Y
- Subjects
- Aluminum Hydroxide, Animals, Disease Models, Animal, Goblet Cells pathology, Immunoglobulin E blood, Interleukin-13 blood, Male, Nasal Mucosa pathology, Ovalbumin, Random Allocation, Rats, Rats, Wistar, Rhinitis, Allergic blood, Rhinitis, Allergic chemically induced, Rhinitis, Allergic pathology, Symptom Assessment, Antioxidants therapeutic use, Melatonin therapeutic use, Rhinitis, Allergic drug therapy
- Abstract
Objective: We aimed to investigate the therapeutic effects of melatonin in an experimental AR model., Methods: Thirty-two Wistar rats were randomised into four groups (n = 8 each). The experimental AR model was established in the saline (SF), ethanol, and melatonin groups via intraperitoneal (i.p.) injections and intranasal application of ovalbumin. The SF, ethanol, and melatonin groups received daily i.p. saline, 2% ethanol dissolved in saline, and 10 mg/kg melatonin dissolved in 2% ethanol and saline. The control group received the same amount of i.p. and intranasal saline. Total nasal symptom scores were recorded in all rats on days 1 (baseline), 15, 20, 25, and 30. Serum ovalbumin-specific IgE, IL-13, and melatonin levels were measured on days 1 (baseline), 15, and 30. The nasal mucosa of all rats was scored histopathologically., Results: The total nasal symptom scores and serum ovalbumin-specific IgE values of the SF, ethanol, and melatonin groups were significantly higher on day 15 than those of the control group. On day 30, the scores and serum ovalbumin-specific IgE values of the melatonin group were similar to those of the control, whereas the SF and ethanol groups had statistically higher scores. The histological scores of the SF and ethanol groups were significantly higher than those of the control and melatonin groups, but no significant difference was found between the melatonin and control groups., Conclusion: Melatonin reduced total nasal symptom scores and serum ovalbumin-specific IgE levels and improved histological inflammation parameters in the ovalbumin-induced rat experimental AR model., Competing Interests: Declaration of Competing Interest The authors have no conflicts of interest to declare., (Copyright © 2021. Published by Elsevier B.V.)
- Published
- 2021
- Full Text
- View/download PDF
16. The effect of ferulic acid on experimental traumatic brain damage in rats.
- Author
-
Erbil G, Sacik U, Yilmaz F, Kisaoglu H, Erbayraktar Z, Pekcetin C, and Ozogul C
- Subjects
- Animals, Antioxidants, Brain, Malondialdehyde, Rats, Superoxide Dismutase, Anti-Inflammatory Agents, Non-Steroidal pharmacology, Brain Injuries, Traumatic drug therapy, Coumaric Acids pharmacology
- Abstract
Aim: Traumatic brain injury is an important social health problem due to the fact that young adults are more likely to be affected, and advanced functional limitations are observed in survivors. In this study, we aimed to investigate the protective effect of ferulic acid in an experimental trauma model., Material and Methods: This study was performed in March 2016 at Dokuz Eylül University Experimental Animal Laboratory. Subjects were randomly divided into 4 groups Control, Ethyl Alcohol, Trauma, Trauma/Ferulic Acid groups. For histological findings, Cresyl violet; for immunohistochemical analysis, TUNEL and Active Caspase-3 staining were used. For biochemical analysis, Superoxide dismutase, Malondialdehyde, and Glutathione values were examined., Results: The application of ferulic acid has been shown to primarily reduce neuronal apoptosis, the levels of free radicals, and to effect oxidant/antioxidant balance positively by increasing the levels of antioxidants, such as Superoxide dismutase and Glutathione that are developed due to brain damage. Our study group has shown that ferulic acid decreased nerve tissue pathologies after generated brain trauma compared to injury groups., Conclusion: Addition of ferulic acid to the traditional head trauma treatment has the strength, and ability to increase the rate, and percentage of healing (Tab. 2, Fig. 4, Ref. 28).
- Published
- 2019
- Full Text
- View/download PDF
17. Effects of topical intranasal doxycycline treatment in the rat allergic rhinitis model.
- Author
-
Avincsal MO, Ozbal S, Ikiz AO, Pekcetin C, and Güneri EA
- Abstract
Objectives: Allergic rhinitis (AR) is a chronic upper respiratory tract disease that inflames the mucous membranes of the nose and occurs when circulating inflammatory cells including eosinophils and basophils migrate to and accumulate in the inflammation area by passing through the interstitium and capillary walls. To pass through these barriers, the inflammatory cells degrade extracellular matrix proteins. Matrix metalloproteinases (MMPs) released by inflammatory cells mediate the degradation of these proteins. MMPs have synthetic inhibitors and doxycycline, a tetracycline antibiotic, inhibits MMPs. This study investigated the efficiency of intranasal doxycycline in decreasing the symptoms and inflammatory cell infiltration in an animal model of AR., Methods: AR was created in female Wistar rats by repeated intranasal challenge with ovalbumin by intraperitoneal injection. For 15 days, topical intranasal doxycycline was administered one hour before ovalbumin administration. Following intranasal administration, nasal symptoms were scored and the nasal mucosae of all rats were evaluated histopathologically. To investigate tissue changes, hematoxyline-eosin and Alcian blue/periodic acid Schiff stains were used. As well, cilia loss, goblet cell changes, vascular congestion, vascular proliferation, inflammatory cell infiltration, eosinophil infiltration and the degree of hypertrophy in chondrocytes were evaluated with light microscopy., Results: Typical symptoms of AR were decreased by intranasal doxycycline administration. These effects were stable after repeated intranasal ovalbumin administration. Histological evaluation of doxycycline treated rats did not reveal typical inflammatory changes associated with AR., Conclusion: MMPs may have crucial functions in AR and topical intranasal doxycycline, which decreases inflammatory cell infiltration, may offer an alternative therapy for AR.
- Published
- 2014
- Full Text
- View/download PDF
18. The effects of exposure to electromagnetic field on rat myocardium.
- Author
-
Kiray A, Tayefi H, Kiray M, Bagriyanik HA, Pekcetin C, Ergur BU, and Ozogul C
- Subjects
- Animals, Apoptosis radiation effects, Glutathione Peroxidase metabolism, Immunohistochemistry, Male, Malondialdehyde metabolism, Myocardium enzymology, Myocardium metabolism, Myocardium pathology, Oxidative Stress radiation effects, Rats, Rats, Wistar, Statistics, Nonparametric, Superoxide Dismutase metabolism, Electromagnetic Fields adverse effects, Heart radiation effects
- Abstract
Exposure to electromagnetic fields (EMFs) causes increased adverse effects on biological systems. The aim of this study was to investigate the effects of EMF on heart tissue by biochemical and histomorphological evaluations in EMF-exposed adult rats. In this study, 28 male Wistar rats weighing 200-250 g were used. The rats were divided into two groups: sham group (n = 14) and EMF group (n = 14). Rats in sham group were exposed to same conditions as the EMF group except the exposure to EMF. Rats in EMF group were exposed to a 50-Hz EMF of 3 mT for 4 h/day and 7 days/week for 2 months. After 2 months of exposure, rats were killed; the hearts were excised and evaluated. Determination of oxidative stress parameters was performed spectrophotometrically. To detect apoptotic cells, terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) staining and caspase-3 immunohistochemistry were performed. In EMF-exposed group, levels of lipid peroxidation significantly increased and activities of superoxide dismutase and glutathione peroxidase decreased compared with sham group. The number of TUNEL-positive cells and caspase-3 immunoreactivity increased in EMF-exposed rats compared with sham. Under electron microscopy, there were mitochondrial degeneration, reduction in myofibrils, dilated sarcoplasmic reticulum and perinuclear vacuolization in EMF-exposed rats. In conclusion, the results show that the exposure to EMF causes oxidative stress, apoptosis and morphologic damage in myocardium of adult rats. The results of our study indicate that EMF-related changes in rat myocardium could be the result of increased oxidative stress. Further studies are needed to demonstrate whether the exposure to EMF can induce adverse effects on myocardium.
- Published
- 2013
- Full Text
- View/download PDF
19. Neuroprotective effect of erythropoietin on nandrolone decanoate-induced brain injury in rats.
- Author
-
Tugyan K, Ozbal S, Cilaker S, Kiray M, Pekcetin C, Ergur BU, and Kumral A
- Subjects
- Animals, Apoptosis drug effects, Brain pathology, Brain Chemistry drug effects, Brain Diseases chemically induced, Cell Count, Erythropoietin therapeutic use, Hippocampus chemistry, Hippocampus drug effects, Hippocampus pathology, Male, Neurons drug effects, Neurons pathology, Neuroprotective Agents therapeutic use, Parietal Lobe chemistry, Parietal Lobe drug effects, Parietal Lobe pathology, Prefrontal Cortex chemistry, Prefrontal Cortex drug effects, Prefrontal Cortex pathology, Rats, Rats, Wistar, Anabolic Agents toxicity, Brain drug effects, Brain Diseases prevention & control, Erythropoietin pharmacology, Nandrolone toxicity, Neuroprotective Agents pharmacology
- Abstract
Anabolic-androgenic steroids (AAS) are used in the medical treatment of many disorders. Erythropoietin (EPO) is a hematopoietic cytokine that has anti-apoptotic, anti-oxidative, and anti-inflammatory effects. The aim of the present study is to investigate the neuroprotective effects of EPO in the hippocampus, parietal cortex and prefrontal cortex, in brain damage due to nandrolone decanoate. 35 Wistar male rats were randomly divided into: (1) control group, (2) sham group, (3) nandrolone decanoate group (ND, intramuscular, 10 mg/(kg week), 8 weeks), (4) ND+low dose EPO treated group (ND+L-EPO) and (5) ND+high dose EPO treated group (ND+H-EPO). EPO was administrated by intraperitoneal injection at a dose of 100 U/(kg day) for L-EPO treatment and at a dose of 500 U/(kg day) for H-EPO treatment during 8 weeks. The number of neurons of CA1, CA2, CA3 and dentate gyrus of hippocampus, parietal cortex and prefrontal cortex were significantly less in the ND group compared with the control group. Treatment with H-EPO significantly preserved the number of neurons in hippocampus when compared with ND administrated. Besides, H-EPO treatment decreased the number of TUNEL-positive and active caspase-3 positive cells and MDA levels and increased GPx levels when compared to ND group. In conclusion, abuse of AAS causes reduction in the number of neurons in hippocampus, parietal cortex and prefrontal cortex regions and increases oxidative damage and therefore H-EPO may be useful as a neuroprotective agent in brain injury., (Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.)
- Published
- 2013
- Full Text
- View/download PDF
20. Effects of lipoic acid in an experimentally induced hypertensive and diabetic rat model.
- Author
-
Mıcılı SC, Ergur BU, Ozoğul C, Sarıoğlu S, Bağrıyanık HA, Tuğyan K, Pekcetin C, Sonmez U, Tekmen I, Erbil G, Akdoğan GG, Ozyurt D, and Buldan Z
- Subjects
- Animals, Diabetes Mellitus, Experimental chemically induced, Diabetic Nephropathies prevention & control, Disease Models, Animal, Hypertension etiology, Male, Nephrectomy adverse effects, Rats, Rats, Wistar, Streptozocin adverse effects, Diabetes Mellitus, Experimental drug therapy, Hypertension drug therapy, Thioctic Acid therapeutic use
- Abstract
In this study, experimental diabetes and nephrectomy have been applied separately and together in order to investigate the possible therapeutic effects of lipoic acid (LA) on hypertensive and diabetic rat kidneys. Wistar rats were divided into eight groups: control, diabetes mellitus (DM), 5/6 nephrectomy, DM + 5/6 nephrectomy, LA administration, DM + LA treated, 5/6 nephrectomy + LA treated, and DM + 5/6 nephrectomy + LA-treated groups, respectively. Renal damage was evaluated histomorphometrically, ultrastructurally, and biochemically. Our findings supported that diabetes and hypertension together increased the rate of renal injury, and LA had therapeutic effects on hypertensive and diabetic rat kidneys.
- Published
- 2013
- Full Text
- View/download PDF
21. Sustained release spherical agglomerates of polymethacrylates containing mefenamic acid: in vitro release, micromeritic properties and histological studies.
- Author
-
Ozyazici M, Sevgi F, Pekcetin C, Sarpas B, and Sayin S
- Subjects
- Animals, Anti-Inflammatory Agents, Non-Steroidal adverse effects, Anti-Inflammatory Agents, Non-Steroidal pharmacology, Calorimetry, Differential Scanning, Duodenum drug effects, Duodenum pathology, Mefenamic Acid adverse effects, Mefenamic Acid pharmacology, Permeability, Powder Diffraction, Rats, Rats, Wistar, Stomach drug effects, Stomach pathology, X-Ray Diffraction, Anti-Inflammatory Agents, Non-Steroidal administration & dosage, Delayed-Action Preparations chemistry, Mefenamic Acid administration & dosage, Polymethacrylic Acids chemistry
- Abstract
Mefenamic acid (MA) spherical agglomerates (SAs) were prepared with various polymethacrylates having different permeability characteristics (Eudragit RS 100, Eudragit RL 100 and Eudragit L 100) and also with combination of Eudragit RS 100 and Eudragit L 100 in different ratios. SAs were prepared by spherical crystallization method using ethanol/dichloromethane solvent (crystallization) system. The influence of various formulation factors on the encapsulation efficiency, as in vitro drug release, and micromeritic properties was investigated. Target release profile of MA was also drawn. The yields of preparation and the encapsulation efficiencies were high for all formulations. The shape and surface characteristics of SAs were observed by a scanning electron microscope. The particle sizes are in the range of 0.219 ± 0.1 to 0.482 ± 0.25 mm (mean ± confidence interval t(95%)). In addition, histological studies showed that the administration of MA in SAs containing Eudragit RS/L provided a distinct tissue protection in the stomach and duodenum. Differential scanning calorimetry and X-ray diffraction of powder studies showed that MA particles crystallized in the presence of polymethacrylates did not undergo structural modifications.
- Published
- 2012
- Full Text
- View/download PDF
22. Maternal aerobic exercise during pregnancy can increase spatial learning by affecting leptin expression on offspring's early and late period in life depending on gender.
- Author
-
Dayi A, Agilkaya S, Ozbal S, Cetin F, Aksu I, Gencoglu C, Cingoz S, Pekcetin C, Tugyan K, Kayatekin BM, and Uysal N
- Subjects
- Age Factors, Animals, CA1 Region, Hippocampal physiology, CA3 Region, Hippocampal physiology, Cell Survival, Dentate Gyrus physiology, Female, Male, Memory physiology, Neurogenesis, Neuronal Plasticity physiology, Neurons physiology, Pregnancy, Rats, Rats, Wistar, Sex Factors, Statistics, Nonparametric, Maze Learning physiology, Physical Conditioning, Animal physiology, Receptors, Leptin physiology
- Abstract
Maternal exercise during pregnancy has been suggested to exert beneficial effects on brain functions of the offspring. Leptin is an adipocytokine which is secreted from adipose tissues and has positive effects on learning, memory, and synaptic plasticity. In this study, pregnant rats were moderately exercised and we observed the effects of this aerobic exercise on their prepubertal and adult offsprings' spatial learning, hippocampal neurogenesis, and expression of leptin. All the pups whose mothers exercised during pregnancy learned the platform earlier and spent longer time in the target quadrant. Their thigmotaxis times were shorter than those measured in the control group. It is shown that hippocampal CA1, CA3 neuron numbers increased in both prepubertal and adult pups, in addition that GD neuron numbers increased in adult pups. Leptin receptor expression significantly increased in the prepubertal male, adult male, and adult female pups. In our study, maternal running during pregnancy resulted in significant increase in the expression of leptin receptor but not in prepubertal female pups, enhanced hippocampal cell survival, and improved learning memory capability in prepubertal and adult rat pups, as compared to the control group. In conclusion, maternal exercise during pregnancy may regulate spatial plasticity in the hippocampus of the offspring by increasing the expression of leptin.
- Published
- 2012
- Full Text
- View/download PDF
23. The effects of prenatal and neonatal exposure to electromagnetic fields on infant rat myocardium.
- Author
-
Tayefi H, Kiray A, Kiray M, Ergur BU, Bagriyanik HA, Pekcetin C, Fidan M, and Ozogul C
- Abstract
Introduction: Electromagnetic fields (EMF) have adverse effects as a result of widespread use of electromagnetic energy on biological systems. The aim of this study was to investigate the effects of prenatal exposure to EMF on rat myocardium by biochemical and histopathological evaluations., Material and Methods: In this study, 10 pregnant Wistar rats were used. Half of the pregnant rats were exposed to EMF of 3 mT, and the other half to sham conditions during gestation. After parturition, rat pups in the 5 EMF-exposed litters from birth until postnatal day 20 were exposed to EMF of 3 mT for 4 h/day (EMF-exposed group, n = 30). Rat pups in sham litters from birth until postnatal day 20 were exposed to sham conditions (sham group, n= 20)., Results: In the EMF-exposed group, lipid peroxidation levels significantly increased compared to sham. Superoxide dismutase activities decreased significantly in the EMF-exposed group compared to sham. TUNEL staining showed that the number of TUNEL-positive cells increased significantly in EMF-exposed rats compared with sham. Under electron microscopy, there were mitochondrial degeneration, reduction in myofibrils, dilated sarcoplasmic reticulum and perinuclear vacuolization in EMF-exposed rats., Conclusions: In conclusion, the results show that prenatal exposure to EMF causes oxidative stress, apoptosis and morphological pathology in myocardium of rat pups. The results of our study indicate a probable role of free radicals in the adverse effects of prenatal exposure to EMF. Further studies are needed to demonstrate whether the EMF exposure can induce adverse effects on the myocardium.
- Published
- 2010
- Full Text
- View/download PDF
24. The protective effects of carnosine and melatonin in ischemia-reperfusion injury in the rat liver.
- Author
-
Baykara B, Tekmen I, Pekcetin C, Ulukus C, Tuncel P, Sagol O, Ormen M, and Ozogul C
- Subjects
- Alanine Transaminase analysis, Animals, Antioxidants, Aspartate Aminotransferases analysis, Female, Glutathione Transferase analysis, Immunohistochemistry, Injections, Intraperitoneal, Liver injuries, Liver pathology, Microscopy, Peroxidase analysis, Rats, Rats, Wistar, Reperfusion Injury pathology, Carnosine pharmacology, Liver drug effects, Melatonin pharmacology, Reperfusion Injury prevention & control
- Abstract
The reperfusion following liver ischemia results in hepatocyte damage and apoptosis. The aim of this study was to investigate the effects of two antioxidant agents, carnosine and melatonin, in rat liver ischemia-reperfusion injury. Five study groups were formed; I. sham, II. ischemia-reperfusion, III. ischemia-reperfusion+melatonin, IV. ischemia-reperfusion+carnosine, V. ischemia-reperfusion+melatonin+carnosine. Then 250 mg/kg carnosine and 10 mg/kg melatonin were administered intraperitoneally 30 min before ischemia and immediately after the reperfusion. Sinusoidal dilatation, congestion and neutrophil infiltration were observed in the ischemia-reperfusion group while these symptoms were less pronounced in the treatment groups. Alanine aminotransferase, aspartate aminotransferase and myeloperoxidase levels were increased in the ischemia-reperfusion group while they were lowered in the treatment groups. Glutathione level was low in the ischemia-reperfusion group while it tended to increase in the ischemia-reperfusion+carnosine administered and ischemia-reperfusion+carnosine+melatonin administered groups. There was an increase in the number of apoptotic cells in the ischemia-reperfusion group while this number was lowered in the treatment groups. Carnosine was more effective than melatonin in the reversal of structural and biochemical alterations that resulted from ischemia-reperfusion injury. The administration of melatonin and carnosine together yielded better outcomes compared to the sole administration of each agent.
- Published
- 2009
- Full Text
- View/download PDF
25. Protective effects of deprenyl in transient cerebral ischemia in rats.
- Author
-
Kiray M, Bagriyanik HA, Pekcetin C, Ergur BU, and Uysal N
- Subjects
- Animals, Escape Reaction drug effects, Hippocampus drug effects, Male, Maze Learning drug effects, Memory Disorders prevention & control, Monoamine Oxidase Inhibitors therapeutic use, Rats, Rats, Wistar, Superoxide Dismutase metabolism, Thiobarbituric Acid Reactive Substances metabolism, Ischemic Attack, Transient prevention & control, Selegiline therapeutic use
- Abstract
Cerebral ischemia leads to neuronal damage in the hippocampus and cognitive decline. Reactive oxygen species play an important role in the neuronal loss after cerebral ischemia and reperfusion injury. Deprenyl, an irreversible monoamine-oxidase B inhibitor, has antioxidant and neuroprotective effects against reactive oxygen species. In the present study, the effect of deprenyl on spatial memory impairment, oxidative stress and apoptotic neuronal cell death following transient cerebral ischemia in rats was investigated. Transient ischemia was induced by occlusion of left common carotid artery of rats for 30 min and reperfusion for 24 h or 1 week. Rats received intraperitoneal injection of 1 mg/kg deprenyl (n = 24) or equal volume of saline (n = 24) for 14 days before the experiment. Deprenyl treatment attenuated spatial memory deficits following ischemia-reperfusion as measured by the Morris water maze task. Deprenyl treatment elicited a significant decrease in lipid peroxidation and increase in superoxide dismutase activities in ischemic rat brains. The number of TUNEL-positive cells decreased significantly in deprenyl-treated group when compared with the control group. The results show that deprenyl reduces the ischemia-induced oxidative stress and thus prevents spatial memory deficits and apoptotic neuronal cell death when it is administered before ischemia-reperfusion.
- Published
- 2008
26. Neuroprotective effects of selenium and ginkgo biloba extract (EGb761) against ischemia and reperfusion injury in rat brain.
- Author
-
Erbil G, Ozbal S, Sonmez U, Pekcetin C, Tugyan K, Bagriyanik A, and Ozogul C
- Abstract
Objectives: To determine the neuroprotective effects of Ginkgo biloba extract (EGb761) and Selenium (Se), and the combination of these agents on ischemia/reperfusion (I/R) injury in a rat model of transient global cerebral I/R., Methods: This experimental study took place in the Animal Research Laboratory at Dokuz Eylul University, Izmir, Turkey in the year 2006. Fifty rats were subjected to cerebral I/R induced by right carotid artery occlusion technique for a duration of 45 minutes, and then were treated with EGb761 (50 mg/kg/day, ip) and Se (0.625 mg/kg, ip), alone or in combination for 14 days after surgery. Superoxide dismutase, and glutathione peroxidase activities were measured in the hippocampal tissues from 25 animals. Histopathological examinations were also carried out under light and electron microscopy from the rest of animals., Results: The results suggest that EGb761 has a potent neuroprotective effect against cerebral I/R induced injury in rat brain that is comparable with that of Se. However, the combined use of EGb761 and Se does not further protect from neuronal injury when compared with the use of both agents alone., Discussion: Our results suggest that administration of EGb761, Se and its combination with EGb761 have significant neuroprotective effects on I/R injury in rats via suppression of oxidative stress.
- Published
- 2008
27. Protective effect of erythropoietin pretreatment in testicular ischemia-reperfusion injury in rats.
- Author
-
Ergur BU, Kiray M, Pekcetin C, Bagriyanik HA, and Erbil G
- Subjects
- Animals, Antioxidants metabolism, Apoptosis drug effects, Germ Cells metabolism, Germ Cells pathology, Ischemia etiology, Ischemia pathology, Ischemia prevention & control, Male, Random Allocation, Rats, Recombinant Proteins, Reperfusion adverse effects, Reperfusion Injury pathology, Testis metabolism, Testis pathology, Erythropoietin administration & dosage, Premedication, Protective Agents administration & dosage, Reperfusion Injury drug therapy, Spermatic Cord Torsion therapy, Testicular Diseases drug therapy, Testis blood supply
- Abstract
Background/purpose: This study was designed to investigate the effects of recombinant erythropoietin (EPO), a hormone widely used for treatment of uremic anemia, in rats subjected to testicular ischemia and reperfusion (I/R)., Methods: Thirty-five male rats were divided into the following: control, sham operated, ischemia (I), I/R, and I/R + EPO groups. In the I group, 2 hours of left unilateral testicular torsion were performed, and in the I/R and I/R + EPO groups, an additional 2 hours of testicular detorsions were performed. The I/R + EPO group was pretreated intraperitoneally with EPO (500 IU/kg) before reperfusion. Testicular tissue samples were examined for biochemical and histopathologic parameters. Apoptotic cells in all testes were detected by terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling technique and caspase 3 immunohistochemistry., Results: At histopathologic examination, ischemic changes in primary spermatocytes were noted in all torted testes. Cellular damage and apoptosis were more severe in ischemic groups than the EPO-pretreated group. There were statistically significant differences in tissue biochemical parameters in the I and I/R groups compared with the I/R + EPO group., Conclusions: The results of the present study suggest that EPO exerts protective effects against I/R injury via the modulation of free radical scavenger's activities, which decreases lipid peroxidation levels and attenuation of apoptosis.
- Published
- 2008
- Full Text
- View/download PDF
28. A comparative histological study of alginate beads as a promising controlled release delivery for mefenamic acid.
- Author
-
Sevgi F, Kaynarsoy B, Ozyazici M, Pekcetin C, and Ozyurt D
- Subjects
- Administration, Oral, Animals, Anti-Inflammatory Agents, Non-Steroidal toxicity, Carboxymethylcellulose Sodium chemistry, Chemistry, Pharmaceutical, Delayed-Action Preparations, Gastric Mucosa drug effects, Gels, Glucuronic Acid chemistry, Hexuronic Acids chemistry, Intestinal Mucosa drug effects, Mefenamic Acid toxicity, Rats, Rats, Wistar, Toxicity Tests, Alginates chemistry, Anti-Inflammatory Agents, Non-Steroidal administration & dosage, Drug Carriers chemistry, Mefenamic Acid administration & dosage
- Abstract
The new mefenamic acid-alginate bead formulation prepared by ionotropic gelation method using 3 x 2(2) factorial design has shown adequate controlled release properties in vitro. In the present study, the irritation effects of mefenamic acid (MA), a prominent non-steroidal anti-inflammatory (NSAI) drug, were evaluated on rat gastric and duodenal mucosa when suspended in 0.5% (w/v) sodiumcarboxymethylcellulose (NaCMC) solution and loaded in alginate beads. Wistar albino rats weighing 200 +/- 50 g were used during in vivo animal studies. In this work, biodegradable controlled release MA beads and free MA were evaluated according to the degree of gastric or duodenal damage following oral administration in rats. The gastric and duodenal mucosa was examined for any haemorrhagic changes. Formulation code A10 showing both Case II transport and zero order drug release and t(50) % value of 5.22 h was chosen for in vivo animal studies. For in vivo trials, free MA (100 mgkg(-1)), blank and MA (100 mgkg(-1)) loaded alginate beads (formulation code A10) were suspended in 0.5% (w/v) NaCMC solution and each group was given to six rats orally by gavage. NaCMC solution was used as a control in experimental studies. In vivo data showed that the administration of MA in alginate beads prevented the gastric lesions.
- Published
- 2008
- Full Text
- View/download PDF
29. The protective effects of trimetazidine on testicular ischemia and reperfusion injury in rats.
- Author
-
Pekcetin C, Ergur BU, Kiray M, Bagriyanik A, Tugyan K, Erbil G, and Ozogul C
- Subjects
- Animals, Apoptosis drug effects, Caspase 3 biosynthesis, Disease Models, Animal, Follow-Up Studies, Immunohistochemistry, In Situ Nick-End Labeling, Ischemia metabolism, Ischemia pathology, Male, Oxidative Stress drug effects, Rats, Rats, Wistar, Reperfusion Injury metabolism, Reperfusion Injury pathology, Spermatic Cord Torsion complications, Spermatozoa drug effects, Spermatozoa pathology, Treatment Outcome, Ischemia prevention & control, Reperfusion Injury prevention & control, Testis blood supply, Trimetazidine therapeutic use, Vasodilator Agents therapeutic use
- Abstract
This study was designed to investigate the protective effect of trimetazidine [TMZ; 1-(2, 3, 4-trimethhoxibenzyl)-piperazine dihydrochloride], as an antioxidant agent, on torsion-detorsion-induced biochemical and histopathological changes in experimental testicular ischemia/reperfusion injury in rats. Twenty-seven male Wistar rats weighing 180-220 g were divided into five groups: control (C, n = 4), sham-operated (S, n = 4), ischemia (I, n = 6), ischemia-reperfusion (I/R, n = 6) and ischemia-reperfusion + trimetazidine (I/R + TMZ; n = 7). Control rats were used for basal normal values. In group I, 2 h torsion of the left testis was performed. In I/R and I/R + TMZ groups, following 2 h of torsion, 4 h detorsion of the testis was performed. In ischemia and I/R groups, physiologic saline was administered orally for 7 days, and the rats in I/R + TMZ group were pretreated orally with 5 mg/kg day TMZ for 7 days before inducing ischemia. At the end of each experiment, ipsilateral orchiectomies were performed for the tissue levels of malondialdehyde (MDA), glutathione peroxidase (GPx) enzyme activities and histopathological examinations in all groups. MDA levels were significantly reduced and GPx enzyme activities were significantly increased in testes in I/R+TMZ pretreated group compared to group I and I/R. The mean seminiferous tubular diameter (MSTD) and Johnsen's score were significantly better in I/R+TMZ group than groups I and I/R. Pretreatment with TMZ decreased germ cell apoptosis and caspase-3 expression in the ischemic testis. The present results show that TMZ has a protective activity in the testicular injury caused by I/R, and provide the first evidence of the role of TMZ for the prevention of I/R-induced testicular injury.
- Published
- 2007
- Full Text
- View/download PDF
30. Suppression of apoptosis and oxidative stress by deprenyl and estradiol in aged rat liver.
- Author
-
Kiray M, Ergur BU, Bagriyanik A, Pekcetin C, Aksu I, and Buldan Z
- Subjects
- Animals, Female, In Situ Nick-End Labeling, Lipid Peroxidation drug effects, Liver cytology, Liver metabolism, Ovariectomy, Rats, Rats, Wistar, Thiobarbituric Acid Reactive Substances metabolism, Aging, Apoptosis drug effects, Estradiol pharmacology, Liver drug effects, Oxidative Stress drug effects, Selegiline pharmacology
- Abstract
Aging is accompanied by significant structural and functional transformations of all organs and systems. Age-associated increase in apoptotic behavior may cause disease. Older cells are more susceptible to endogenous oxidative damage, and oxidative stress is a potent inducer of apoptosis. Deprenyl is an irreversible monoamine-oxidase B inhibitor which has anti-oxidant, anti-apoptotic and neuroprotective effects. Estrogen is also a neuroprotective and anti-oxidant hormone. The objectives of this study were to determine whether the anti-oxidative effects of deprenyl can suppress apoptotic activity, with or without estradiol, in aged female rat livers. In this study, ovariectomized female Wistar albino rats were divided into six groups as follows; young (3 months old) saline-treated control, aged (24 months old) saline-treated control, aged deprenyl treated, aged estradiol treated, aged deprenyl plus estradiol treated and aged sham controls. All rats except for the sham group were treated for 21 days. Determination of oxidative stress parameters was performed spectrophotometrically. To detect apoptotic cells, TUNEL staining was performed. The results were analyzed by one-way ANOVA post hoc Bonferroni test. Deprenyl and estradiol administration, alone or in combination, decreased significantly the levels of lipid peroxidation and increased superoxide dismutase activity in the liver relative to aged control and sham rats (P<0.05). The number of TUNEL positive cells decreased significantly in deprenyl and estradiol-treated rats compared with aged control and sham rats. The results indicate that deprenyl treatment alone, or in combination with estradiol, may modulate age-related apoptotic changes in rat liver by decreasing oxidative stress.
- Published
- 2007
- Full Text
- View/download PDF
31. In vitro release--in vivo microbiological and toxicological studies on ketoconazole lipid granules.
- Author
-
Ozyazici M, Gokce EH, Ozer O, Ay Z, Guneri T, Ertan G, Gokce G, Metin DY, Hilmioglu S, Durmaz G, Yalcin A, Pekcetin C, and Ozyurt D
- Subjects
- Aluminum Hydroxide administration & dosage, Animals, Antacids administration & dosage, Antifungal Agents administration & dosage, Antifungal Agents chemistry, Antifungal Agents toxicity, Candida albicans, Delayed-Action Preparations, Drug Antagonism, Female, Glutathione blood, In Vitro Techniques, Ketoconazole administration & dosage, Ketoconazole chemistry, Ketoconazole toxicity, Liver pathology, Magnesium Hydroxide administration & dosage, Mice, Stomach pathology, Tablets, Vagina pathology, Antifungal Agents therapeutic use, Candidiasis, Vulvovaginal drug therapy, Excipients, Fatty Acids, Glycerol analogs & derivatives, Ketoconazole therapeutic use, Polyethylene Glycols
- Abstract
In some multidrug therapy programs, ketoconazole (KTZ) may be administered with some antacids that could modify its dissolution rate and reduce its absorption, thus leading to therapeutic failures. The primary aim of this study was to evaluate the influence of Compritol HD5 ATO and Compritol 888 ATO on this interaction in comparison with commercial KTZ tablets. The second aim was to prepare lipid granules of KTZ that could be an alternative to the commercial formulation. Therefore, six KTZ sustained-release granules were prepared with different lipid concentrations, because they were found to be more suitable than tablets that are dissolved only in gastric medium. The results confirmed that the dissolution rate of KTZ granules was significantly reduced in the presence of antacids. The ideal formulation was selected as granules including 5% of Compritol lipids in relation to the suitability of the target profile. Therapeutic effects of orally administered, ideal KTZ granule formulations, and commercial tablets were evaluated in vivo by the experimental model of murine vulvo-vaginal candidiasis (VVC) with and without antacids. It was found that formulations were very effective on VVC, and the therapeutic effect decreased significantly in the presence of antacids. Histopathological studies were carried out for vagina, stomach, and liver tissues and hepatoxicity was also examined. The levels of reduced glutathione (GSH) were measured to assess the oxidative stress induced by KTZ and function of the liver. It was observed that orally administered formulations of KTZ were successful in treating candidiasis in mice without irritancy in stomach. However, liver tissues were damaged. The decreased GSH levels indicated toxicity in our study. This study suggested that in vitro release and in vivo microbiological-toxicological properties of KTZ were affected by antacids and drug-excipient interactions. Lipid granules of KTZ prepared with Compritol 888 ATO could be proposed as a new KTZ solid dosage form with optimum dissolution and therapeutic characteristics.
- Published
- 2007
- Full Text
- View/download PDF
32. Protective effect of melatonin against maternal deprivation-induced acute hippocampal damage in infant rats.
- Author
-
Tugyan K, Uysal N, Ozdemir D, Sonmez U, Pekcetin C, Erbil G, and Sonmez A
- Subjects
- Acute Disease, Animals, Benzoxazines, Coloring Agents, Female, In Situ Nick-End Labeling, Male, Neurons pathology, Oxazines, Rats, Rats, Wistar, Stress, Psychological pathology, Hippocampus pathology, Maternal Deprivation, Melatonin pharmacology, Stress, Psychological prevention & control
- Abstract
It is known that maternal deprivation induces hippocampal damage in the developing brains. In the present study, we examined the effects of melatonin on maternal deprivation-induced hippocampal damage both during and after stress-hyporesponsive period (SHRP). Hippocampal damage was examined by cresyl violet staining and terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) assay. The results showed that a single episode of maternal deprivation for 24 h at post-SHRP induced neuronal loss in hippocampus regions of the brain in the infant rats, while it did not influence hippocampal neurons in SHRP. Melatonin prevented maternal deprivation-induced hippocampal damage in the infant rats at post-SHRP. These results suggest that melatonin is a potentially beneficial agent to improve the neurobehavioral outcomes of maternal deprivation in later developmental period.
- Published
- 2006
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.